Search Results - "Bernabe, Luis Feo"
-
1
Preclinical evaluation of the novel, orally bioavailable Selective Inhibitor of Nuclear Export (SINE) KPT-335 in spontaneous canine cancer: results of a phase I study
Published in PloS one (04-02-2014)“…The purpose of this study was to evaluate the activity of Selective Inhibitors of Nuclear Export (SINE) compounds that inhibit the function of the nuclear…”
Get full text
Journal Article -
2
Multimodal treatment approach in a case of feline ventral abdominal angiosarcoma
Published in Veterinary record case reports (01-02-2019)“…A 14-year-old male neutered domestic shorthair cat presented for a recurrent angiosarcoma. Previously, the mass was incompletely resected twice at the…”
Get full text
Journal Article -
3
A retrospective review of cats with suspected false positive results in point-of-care feline leukemia virus tests and concurrent immune-mediated anemia
Published in Journal of the American Veterinary Medical Association (01-10-2023)“…To describe clinical findings, diagnosis, treatment, and survival in 18 cats with anemia of suspected immune-mediated origin (ASIMO) and conflicting results…”
Get full text
Journal Article -
4
Successful Treatment of 3 Dogs With Fluoroquinolone-Resistant Escherichia coli Associated Granulomatous Colitis
Published in Topics in companion animal medicine (01-03-2022)“…Successful resolution of Escherichia coli associated granulomatous colitis (ECGC) is becoming a challenge due to the development of fluoroquinolone resistant E…”
Get full text
Journal Article -
5
Feline leishmaniosis: diagnosis, treatment and outcome in 16 cats
Published in Journal of feline medicine and surgery (01-10-2020)“…Objectives Leishmaniosis is a vector-borne disease and in European countries is caused by Leishmania infantum. Cats are considered secondary reservoirs of the…”
Get full text
Journal Article -
6
Evaluation of the adverse event profile and pharmacodynamics of toceranib phosphate administered to dogs with solid tumors at doses below the maximum tolerated dose
Published in BMC veterinary research (30-09-2013)“…BACKGROUND: The receptor kinase inhibitor toceranib phosphate (Palladia) was approved for use in dogs in 2009 using a dose of 3.25 mg/kg administered every…”
Get full text
Journal Article -
7
Abstract 3809: Evaluation of the novel, orally bioavailable selective inhibitor of nuclear export (SINE) KPT-335 (verdinexor) in spontaneous canine cancer: Results of phase I and phase II clinical trials
Published in Cancer research (Chicago, Ill.) (01-10-2014)“…SINE (Selective Inhibitors of Nuclear Export) block the activity of XPO1/CRM1, 1 of 7 nuclear export proteins in cells, forcing the nuclear retention of key…”
Get full text
Journal Article -
8
Preclinical Evaluation of the Novel, Orally Bioavailable Selective Inhibitor of Nuclear Export
Published in PloS one (04-02-2014)“…Background The purpose of this study was to evaluate the activity of Selective Inhibitors of Nuclear Export (SINE) compounds that inhibit the function of the…”
Get full text
Journal Article -
9
Evaluation Of The Novel, Orally Bioavailable Selective Inhibitor Of Nuclear Export (SINE) Verdinexor (KPT-335) In Spontaneous Canine Cancer: Results Of Phase I and Phase II Clinical Trials
Published in Blood (15-11-2013)“…SINE (Selective Inhibitors of Nuclear Export) block the activity of XPO1/CRM1, 1 of 7 nuclear export proteins in cells, forcing the nuclear retention of key…”
Get full text
Journal Article -
10
Preclinical Evaluation of the Novel, Orally Bioavailable Selective Inhibitor of Nuclear Export (SINE) KPT-335 in Spontaneous Canine Cancer: Results of a Phase I Study: e87585
Published in PloS one (01-02-2014)“…Background The purpose of this study was to evaluate the activity of Selective Inhibitors of Nuclear Export (SINE) compounds that inhibit the function of the…”
Get full text
Journal Article -
11